lems in patients with heart failure. 1, 2 Ventricular remodeling involves numerous processes, involving molecular alterations, myocardial changes, and the abnormal geometry of the chamber. As a consequence of myocardial infarction (MI), ventricular remodeling occurs immediately as an adaptive response to maintain cardiac output. 3 However, ventricular function and prognosis deteriorate with ongoing remodeling. MI triggers an inflammatory response, including cytokine activation, a cascade of intracellular signaling, and neurohormonal activation 4, 5 These processes result in scar formation and myocyte loss through necrosis, apoptosis, and autophagy. 6 An MI has been shown to be a prominent inducer of cardiomyocyte apoptosis, which, in turn, may contribute to progressive postinfarction remodeling, as demonstrated by recently reported animal and human studies. 7 Yet, the pathophysiological mechanisms of apoptosis in cardiac myocytes remain unclear. The elucidation of the mechanisms of cardiomyocyte apoptosis may lead to an improved understanding of postinfarction remodeling and thereby possibly improve patient care.
Cardiomyocytic apoptosis post-MI is induced by angiotensin II and ␤1-adrenergic stimulation, reactive oxygen species, overstretch, and nitric oxide. 8 Apoptotic programmed cell death is characterized by DNA fragmentation attributable to the activation of an endogenous endonuclease. This endonuclease-mediated breakdown of DNA in apoptosis is activated through "caspase-dependent" pathways or "caspase-independent" pathways ( Figure) . 9 Caspase-dependent pathways in apoptosis have 3 major cascades. One, the endoplasmic reticulum stress induced by extracellular or intracellular death signals activates caspase-12. Two, the mitochondrial stress induced by death signals stimulates the release of cytochrome c, resulting in the activation of caspase-9. Three, the death ligand binding induces death receptors to recruit FADD (Fas-associated death domain) and/or TRADD (tumor necrosis factor receptor-I-associated death domain), and caspase-8 is activated. These 3 cascades induce caspase-3 activation, leading to the cleavage of downstream targets of caspase-3, including the ICAD (inhibitor of CAD [caspase-3-activated DNase]) and PARP (poly[ADP-ribose] polymerase). Finally, endonuclease is activated, which induces DNA fragmentation.
Caspase-independent pathways include the p38 mitogenactivated protein kinase signaling cascade and apoptosisinducing factor. 10 Apoptosis is also regulated by a number of factors. Bax and Bid stimulate apoptogenic release, whereas activation of the pathway is prevented by the antiapoptotic proteins, including Bcl-2 and Akt.
Gelsolin
Gelsolin is an actin binding protein that has multiple actin regulatory activities, including cytoskeletal remodeling and ion channel regulation. [11] [12] [13] In addition, gelsolin has both antiapoptotic and proapoptotic functions. 12, 13 Gelsolin mRNA expression is elevated and plasma gelsolin concentrations are decreased in patients with ischemic heart disease, as demonstrated by recent reports. 14, 15 Increased expression of gelsolin was also demonstrated in animal models of heart failure. 14 These data suggest that gelsolin may play an important role in cardiac remodeling post-MI.
In this of Circulation Research, Li et al 16 elegantly clarified the role of gelsolin in postinfarction remodeling and the mechanism by which gelsolin stimulated apoptosis, using gelsolin-null mice and wild-type littermates with left anterior descending coronary artery ligation. Survival was improved and end-diastolic volume decreased at 4 weeks post-MI in the absence of gelsolin. To measure the left ventricular volume, the microtip conductance catheters were used. This is an elegant and accurate method for hemodynamic measurements in mice. 2, 4 In addition, less apoptosis was identified in the ischemic border zone of gelsolin-null mice post-MI by using the TUNEL assay and DNA laddering experiments. Microarray analysis and quantitative real-time RT-PCR revealed that DNase I was the most prominently changed gene among genes related to the stress response, pro-and antiapoptotic factors, and actin-binding proteins. Li et al 16 noted these results strongly suggested a link between the presence of gelsolin and the induction of apoptosis post-MI.
Mechanisms of Gelsolin-induced Apoptosis
In multiple cell types, gelsolin is cleaved by caspase-3, which is activated during apoptosis. 12, 13, 17, 18 Gelsolin is also cleaved during apoptosis by caspase-8 and tumor necrosis factor. 12, 13 The N-terminal gelsolin fragment loses the Ca 2ϩ control of the severing activity and the capacity to bind monomeric actin, triggering rapid depolymerization of the actin cytoskeleton. Expression of the N-terminal gelsolin leads to upregulation of apoptosis. Conversely, gelsolin has been reported to inhibit apoptosis. Possible mechanisms have been proposed to explain the inhibitory capacity of gelsolin. Gelsolin in complex with phosphoinositides can competitively inhibit caspase-3. 19 Despite all of these data, the effects of gelsolin on apoptosis remain controversial. Li et al 16 demonstrated that gelsolin and cleaved gelsolin expression in the wild-type mice was increased and redistributed and that activated caspase-3 and caspase-8 were increased in the wild-type mice post-MI by immunoblotting analysis. In addition, the increase in caspase-3 post-MI functioned only in the presence of gelsolin. These data suggest that gelsolin cleaved by caspase-3 and caspase-8 upregulates MI-induced cardiomyocyte apoptosis (Figure) .
Li et al 16 noted DNase I was a gelsolin-related endonuclease during apoptosis in the myocyte post-MI. Immunoblotting with a specific anti-DNase I antibody showed less nuclear translocation of DNase I, and the biological activity of DNase I was lower in the gelsolin-null mice post-MI. In addition, immunostaining showed the nuclear translocation of DNase I and its involvement in apoptotic cells. Interestingly, gelsolin also translocated into nuclei post-MI, suggesting that gelsolin directly induced the expression of DNase I by transcriptional activation. Indeed, it has been reported that gelsolin enhances the transcriptional activity of androgen receptor in the presence of an agonist. 20 How is the transcription of DNase I regulated in cardiac myocytes during apoptosis post-MI? Hypoxia-inducible factor (HIF)-1␣ is a transcription factor, and is a key regulator of hypoxic conditions. 21 Li et al 16 demonstrated HIF-1␣ could bind to the promoter region of DNase I and that HIF-1␣ was strongly expressed in the wild-type mice post-MI. Immunoprecipitation assays revealed that HIF-1␣ coprecipitated with gelsolin in vivo and in vitro. Electrophoretic mobility-shift assays confirmed the functional interactions of HIF-1␣ with the DNase I promoter. In fact, luciferase assays showed that the relative luminescence was significantly increased after cotransfection of HIF-1␣ and DNase I promoter vectors.
These data suggested HIF-1␣ contributed to the transcription of DNase I in cardiac myocytes during apoptosis post-MI. Interestingly, it has been reported that HIF-1␣ regulates the transcription of gelsolin gene expression in fibroblasts under hypoxic conditions. 22 HIF-1␣ possibly contributes to the transcription of gelsolin in cardiac myocytes during apoptosis post-MI.
Finally, Li et al 16 demonstrated the cleavage of downstream targets of caspase-3 and caspase-8, including the DNA fragmentation factor-45/ICAD, which interacts DNA fragmentation factor-40/CAD. Bid was not significantly different between the gelsolin genotypes. In contrast, the survival signals involving activated Akt and Bcl-2 were preserved in the gelsolin null mice post-MI on immunoblotting analysis.
Taken together, the data from the present article suggest that gelsolin may promote apoptosis in vivo through DNase I in collaboration with HIF-1␣ and that gelsolin may be related to the downregulation of survival factors in cardiomyocytic apoptosis post-MI through the caspase cleavage of PARP, reduction of Akt activation, and decrease of Bcl-2 expression.
Clinical Application
These findings suggest that gelsolin is a new target for post-MI and heart failure treatment. However, in terms of clinical application, it must be noted that antiapoptotic therapies may cause carcinogenesis and that the inhibition of gelsolin may lead to diastolic dysfunction. 12, 13 Indeed, it has been reported that gelsolin expression is downregulated in tumors during carcinogenesis. In addition, a high level of gelsolin expression occurs in early stage non-small cell lung cancer, and it provides highly significant negative prognostic information. However, it has been reported that the gelsolinnull mice showed no increased incidence of tumors. 13 In addition, L-type Ca 2ϩ channel activity may be influenced in myocytes isolated from hearts of gelsolin knockout mice. 12, 23 Li et al 16 noted that compared with the wild-type mice, the gelsolin-null mice post-MI had smaller left ventric- ular end-diastolic volume and nonstatistically increased enddiastolic pressure, which may be attributable to the actin filament stabilization. Left ventricular stiffness may be increased by gelsolin inhibition.
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